Investigation on the molecular mechanism of NPC1L1-mediated cholesterol uptake
Investigation on the molecular mechanism of NPC1L1-mediated cholesterol uptake
批准号:
18390047
负责人:
ITO Kousei
金额:
$6.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
累积证据表明,Niemann-Pick Cl-like 1(NPClL1)是肠道胆固醇吸收所必需的,也是新型降胆固醇药物依折麦布的靶标。在本项目中,我们分离了人NPClL1基因,并构建了高表达人NPClL1的Caco-2细胞。NPClL1蛋白主要表达于肠顶膜,反映了NPClL1在肠刷状缘膜上的生理性表达。胆固醇转运活性与NPClL1的表达水平呈正相关,依折麦布以浓度依赖的方式抑制NPClL1的摄取。此外,由于已证实胆固醇通过多种转运体和/或受体跨质膜的转移与磷脂的转移有关,我们研究了NPClL1对胆固醇的摄取是否也发生在脂质相关的机制中。结果发现,NPClL1过表达导致胆固醇和磷脂酰胆碱从由胆固醇、磷脂酰胆碱和牛磺胆酸盐组成的胶束中摄取增加,但胆固醇的转运活性远高于磷脂酰胆碱。此外,磷脂酰胆碱的摄取对依折麦布的敏感性远低于胆固醇的摄取。相比之下,NPClL1介导的牛磺胆酸盐摄取很少。研究还表明,胆固醇的存在不会影响胶束对磷脂酰胆碱和牛磺胆酸盐的摄取和对ezetimibe的敏感性。这些结果表明,尽管NPClL1具有较强的从胶束中摄取磷脂的活性,但胆固醇是NPClL1在胶束成分中较好的底物,而依折麦布的抑制作用对胆固醇摄取具有相对选择性。
英文摘要
Cumulative evidence suggests that Niemann-Pick Cl-like 1 (NPClL1) is essential for intestinal cholesterol absorption and is the target of ezetimibe, a novel cholesterol-lowering drug. In this project, we isolated human NPClL1 cDNA and constructed human NPClL1-overexpressing Caco-2 cells. NPClL1 protein was mainly detected on the apical membrane, which reflects the physiological expression of NPClL1 on the intestinal brush border membrane. It was also shown that the transport activities of cholesterol were positively correlated with the expression level of introduced NPClL1 and ezetimibe inhibited the uptake in a concentration-dependent manner. In addition, since it has also been established that the transfer of cholesterol across the plasma membrane via many kinds of transporters and/or receptors is associated with the transfer of phospholipids, we examined whether the uptake of cholesterol by NPClL1 also takes place in the lipid-associated mechanism. It was found that overexpression of NPClL1 results in an increase in the uptake of both cholesterol and phosphatidylcholine from micelles composed of cholesterol, phosphatidylcholine and taurocholate but that the level of transport activity for cholesterol was much higher than that for phosphatidylcholine. In addition, the uptake of phosphatidylcholine was much less sensitive to ezetimibe than the uptake of cholesterol. In contrast, NPClL1-mediated uptake of taurocholate was minimal. It was also demonstrated that the uptake and ezetimibe-sensitivity of phosphatidylcholine and taurocholate from the micelles were not affected by the presence of cholesterol. Taken together, the results suggested that cholesterol is a preferable substrate of NPClL1 in micellar components and the inhibitory effect of ezetimibe is relatively selective to cholesterol uptake, although NPClL1 has potent activity for uptake of phospholipids from micelles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Down-regulation of hepatic transporters for BSP in rats with indomethacin-induced intestinal injury.
吲哚美辛诱导的肠道损伤大鼠中 BSP 肝脏转运蛋白的下调。
DOI:
--
发表时间:
2007
期刊:
Biol. Pharm. Bull. 30 (3)
影响因子:
--
作者:
[Fujiyama N, Shitara Y, Ito K, Masubuchi Y, Horie T]
通讯作者:
Horie T
DOI:
10.1016/j.freeradbiomed.2006.02.015
发表时间:
2006-06
期刊:
Free radical biology & medicine
影响因子:
7.4
作者:
[Shuichi Sekine;Kousei Ito;T. Horie]
通讯作者:
Shuichi Sekine;Kousei Ito;T. Horie
Cholesterol lowering effect of ezetimibe in UDP-glucuronosyl transferase (UGT) 1A deficient (Gunn) rats
依折麦布对 UDP-葡萄糖醛酸转移酶 (UGT) 1A 缺陷 (Gunn) 大鼠的胆固醇降低作用
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[Takehito Yamamoto, Kousei Ito, Masashi Honma, Tappei Takada, Hiroshi Suzuki]
通讯作者:
Hiroshi Suzuki
Cholesterol-lowering effect of ezetimibe in uridine diphosphate glucuronosyltransferase 1A-dedicient (Gunn) rats
依折麦布对尿苷二磷酸葡萄糖醛酸转移酶 1A 缺陷 (Gunn) 大鼠的降胆固醇作用
DOI:
--
发表时间:
2007
期刊:
Drug Metab Dispos. 35(9)
影响因子:
--
作者:
[Yamamoto T, et. al.]
通讯作者:
et. al.
Cholesterol lowering effect of ezetimibe in UDP-glucuronosyl transferase (UGT) 1A deficient (Gunn) rats.
依折麦布对 UDP-葡萄糖醛酸转移酶 (UGT) 1A 缺陷 (Gunn) 大鼠的胆固醇降低作用。
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[山本武人、その, 他]
通讯作者:
他
共 9 条
Construction of improved lymphocyte transformation test based on the onset and aggravation mechanism of drug-induced liver injury
-
批准号:25670068
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:ITO Kousei
-
依托单位:
Analysis of the molecular mechanism of hepatic GSH decrease during drug induced liver injury.
-
批准号:22790146
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.58万
-
财政年份:2010
-
负责人:ITO Kousei
-
依托单位:
海外基金